Cardiovascular burden of the amyloidogenic V1421 transthyretin variant in black individuals

12 May 2024 (08:30 - 08:38)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Senthil Selvaraj

Duke University School of Medicine, Durham (United States of America)

9 More presentations in this session

Presentation thumbnail

Discussant review - Cardiovascular Burden of the V142I Variant

Doctor M. Merlo (Trieste, IT)

Presentation thumbnail

Incidence and prognosis of respiratory failure in acute heart failure

Doctor O. Miro (Barcelona, ES)

Presentation thumbnail

Discussant review - Patient oxigenation and outcome

Professor S. Price (London, GB)

Presentation thumbnail

Sex-specific clinical outcomes and healthcare resource utilization in the 5 years following hospitalization for heart failure

Doctor T. Averbuch (Calgary, CA)

Presentation thumbnail

Discussant review - PACTHF

Professor I. Pina (Philadelphia, US)

Access the full session

Session thumbnail

Late breaking science: registries

The Event

Event poster

Heart Failure 2024

12 May 2024 08:30 CET

You may be interested in

Congress Presentation

Age dependency of cardiovascular outcomes with the amyloidogenic p142I transthyretin variant among black individuals

22 May 2023

Congress Presentation

Outcomes with early access tafamidis in patients with variant transthyretin amyloid cardiomyopathy

11 May 2026

Congress Presentation

Prevalence, cardiac phenotype and outcomes of TTR variants in the UK Biobank Population

13 May 2024

Congress Presentation

Multimodal screening of transthyretin amyloid cardiomyopathy through artificial intelligence applied to electrocardiographic images and point-of-care ultrasound: a multi-center study

17 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources